Tau tangle burden was also reduced in many brain regions typically affected in cognitively impaired mutation carriers, but tau pathology in the inferior temporal lobe and brain atrophy were at similar levels between the patient and typical cognitively impaired mutation carriers from the cohort, and severe amyloid and tau pathology was later confirmed at postmortem [197]. This evidence concerns the gene MAPT and Brain atrophy.